Suppr超能文献

局部应用钙通道阻滞剂后眼循环的彩色多普勒超声分析

Color Doppler ultrasound analysis of ocular circulation after topical calcium channel blocker.

作者信息

Netland P A, Grosskreutz C L, Feke G T, Hart L J

机构信息

Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston 02114, USA.

出版信息

Am J Ophthalmol. 1995 Jun;119(6):694-700. doi: 10.1016/s0002-9394(14)72772-2.

Abstract

PURPOSE

To investigate the effect of topical administration of the calcium channel blocker verapamil on intraocular pressure and retrobulbar hemodynamics.

METHODS

In this randomized, prospective, double-masked study, we examined the effects of single-dose topical administration of verapamil in ten normal human volunteers by using color Doppler ultrasound imaging to measure hemodynamic parameters. Limitations of this study include single-dose application of verapamil and relatively small sample size.

RESULTS

No systemic effect on heart rate or blood pressure was detected after administration of topical verapamil. The intraocular pressure significantly decreased compared with baseline two hours after topical 0.125% and 0.25% verapamil (P = .015 and .040, respectively). Pourcelot's ratio, an index of vascular resistance, measured in the central retinal artery was significantly reduced after topical application of 0.125% verapamil (P = .008). The change in Pourcelot's ratio primarily resulted from an increased end diastolic velocity in the central retinal artery. No significant differences compared with baseline values were detected in the color Doppler ultrasound measurements of the posterior ciliary arteries and the central retinal vein two hours after topically administered verapamil.

CONCLUSIONS

Topical administration of verapamil decreases intraocular pressure and alters ocular hemodynamics, reducing the vascular resistance index in the central retinal artery.

摘要

目的

研究局部应用钙通道阻滞剂维拉帕米对眼压和球后血流动力学的影响。

方法

在这项随机、前瞻性、双盲研究中,我们通过彩色多普勒超声成像测量血流动力学参数,检测了单剂量局部应用维拉帕米对10名正常人类志愿者的影响。本研究的局限性包括维拉帕米的单剂量应用和相对较小的样本量。

结果

局部应用维拉帕米后未检测到对心率或血压的全身影响。局部应用0.125%和0.25%维拉帕米两小时后,眼压与基线相比显著降低(分别为P = 0.015和0.040)。局部应用0.125%维拉帕米后,视网膜中央动脉测量的血管阻力指数普尔塞洛比值显著降低(P = 0.008)。普尔塞洛比值的变化主要是由于视网膜中央动脉舒张末期速度增加所致。局部应用维拉帕米两小时后,在彩色多普勒超声测量的睫状后动脉和视网膜中央静脉中,未检测到与基线值相比有显著差异。

结论

局部应用维拉帕米可降低眼压并改变眼部血流动力学,降低视网膜中央动脉的血管阻力指数。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验